Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | EVP, General Counsel | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 616,761 |
Ending reported balance
After 2026-03-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-02-27 · Tax withholding · Disposed 26,326 · Balance 782,932 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 2 · 2026-03-02 · Sale · Disposed 6,856 · Balance 776,076 F2: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. Row 3 · 2026-03-02 · Tax withholding · Disposed 16,973 · Balance 759,103 F3: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 4 · 2026-03-02 · Other · Disposed 137,922 · Balance 621,181 F4: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e). Row 5 · 2026-03-03 · Sale · Disposed 4,420 · Balance 616,761 F5: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.
F3: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F4: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e).
F5: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2022 Filed Sep 8, 2022 00:37 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 287,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022168 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,744 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 4,715 | $9.40 | $44,321.00 |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · derivative · entry 6 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F2 · derivative.exercise_date: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 4,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · derivative · entry 5 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 4,715 shares Expires 2022-05-10 F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · derivative.exercise_date: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 2,752 | $9.40 | $25,868.80 |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · derivative · entry 4 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F1 · derivative.exercise_date: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 2,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · derivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 2,752 shares Expires 2022-05-10 F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · derivative.exercise_date: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 4,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. Read SEC document |
| May 10, 2022 Filed May 13, 2022 01:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 2,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017890 · doc4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.